Cargando…
The intersection of vector biology, gene therapy, and hemophilia
Gene therapy is at the forefront of the drive to bring the potential of cure to patients with genetic diseases. Multiple mechanisms of effective and efficient gene therapy delivery (eg, lentiviral, adeno‐associated) for transgene expression as well as gene editing have been explored to improve vecto...
Autores principales: | Lisowski, Leszek, Staber, Janice M., Wright, J. Fraser, Valentino, Leonard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410952/ https://www.ncbi.nlm.nih.gov/pubmed/34485808 http://dx.doi.org/10.1002/rth2.12586 |
Ejemplares similares
-
Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
por: Monahan, Paul E., et al.
Publicado: (2021) -
Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse Model
por: Staber, Janice M., et al.
Publicado: (2016) -
Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013) -
Recent Advances in the Treatment of Hemophilia: A Review
por: Marchesini, Emanuela, et al.
Publicado: (2021) -
Hemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectors
por: Miao, Carol H.
Publicado: (2016)